Clinical Review

2017 Update on obstetrics

These experts discuss the practical clinical implications of new society recommendations for antenatal steroid administration, low-dose aspirin for preeclampsia prevention, chromosomal microarray analysis, and Zika virus infection and pregnancy

Author and Disclosure Information


In this Update we discuss several exciting new recommendations for preventive treatments in pregnancy and prenatal diagnostic tests. Our A-to-Z coverage includes:

  • antenatal steroids in late preterm pregnancy
  • expanded list of high-risk conditions warranting low-dose aspirin for preeclampsia prevention
  • chromosomal microarray analysis versus karyotype for specific clinical situations
  • Zika virus infection evolving information.

Next: New recommendation for timing of late preterm antenatal steroids


Recommended Reading

Three good apps for calculating the date of delivery
MDedge ObGyn
Letters to the Editor: Patient with a breast mass: Why did she pursue litigation?
MDedge ObGyn
Letters to the Editor: Avoid uterine vessels when injecting vasopressin
MDedge ObGyn
FDA warns of false-positive results with Zika IgM test
MDedge ObGyn
Which maternal beta-blockers boost SGA risk?
MDedge ObGyn